Infectious Diseases Society of America
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals
Abstract
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
Source and rights
Published by Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- Infectious Diseases Society of America
- Published
- 1997
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- PubMed
- 9314444



